• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2768604
  • February 2014
  • Region: Global
  • 97 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • F. Hoffmann-La Roche Ltd.
  • MegaCor Diagnostik GmbH
  • Trinity Biotech plc
  • MORE

'Rapid Medical Diagnostic Kits Market (Applications: Clinical Testing, Home-Use, Infectious Disease and Veterinary; Technologies: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

The rapid medical diagnostic kits market is experiencing impressive growth globally because of the continuous increase in demand for preventive management of infectious diseases. Since its introduction, rapid medical diagnostic kits are becoming a vital part of the medical diagnostics industry and the scope of this market has been perpetually increasing in terms of detectable diseases and adoption by end users.

This report studies the global market for rapid diagnostic kits through three major perspectives namely, application areas, technologies and geography. The application segment of this market has been further segmented into three sub-divisions namely clinical testing, home-use and veterinary diagnostics. In addition, the technology segment of rapid medical diagnostic kits market has been categorized into lateral flow, flow-through, agglutination assays and solid phase. Each READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • F. Hoffmann-La Roche Ltd.
  • MegaCor Diagnostik GmbH
  • Trinity Biotech plc
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation: Rapid Medical Diagnostic Kits Market
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Rapid Medical Diagnostic Kits Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.1.1 Global Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Widespread Availability
3.2.1.2 Aging population
3.2.1.3 Shift in Technological and Commercial Environment
3.2.2 Restraints
3.2.2.1 Failure to Eliminate the Need for Microscopy Diagnosis
3.2.2.2 Lack of Awareness
3.2.2.3 Technical and Operational concerns
3.2.3 Opportunities
3.2.3.1 Technological Innovation
3.3 Porter’s Five Forces Analysis: Global Rapid Medical Diagnostic Kits Market
3.3.1.1 Bargaining Power of Suppliers
3.3.1.2 Bargaining power of Buyers
3.3.1.3 Threat of new Entrants
3.3.1.4 Threat of Substitutes
3.3.2 Competitive rivalry
3.4 Market Attractiveness Analysis: Global Rapid Medical Diagnostic Kits Market

Chapter 4 Global Rapid Medical Diagnostic Kits Market, by Applications, 2011 - 2019 (USD Million)
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Comparative Analysis: Global Rapid Medical Diagnostic Kits Market, by Applications (Value %)
4.2 Clinical Testing
4.2.1.1 Global Clinical Testing Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.2.1 Infectious Disease Testing
4.2.1.1 Global Clinical Infectious Disease Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.2.2 Cholesterol Monitoring
4.2.2.1 Global Clinical Cholesterol Monitoring Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.2.3 Substance Abuse Testing
4.2.3.1 Global Clinical Substance Abuse Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.2.4 Fertility & Pregnancy Testing
4.2.4.1 Global Clinical Fertility and Pregnancy Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.2.5 Blood Glucose Testing
4.2.5.1 Global Clinical Blood Glucose Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3 Home-use
4.3.1.1 Global Home-use Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3.1 Blood Glucose Monitoring
4.3.1.1 Global Home-use Blood Glucose Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3.2 Fertility & Pregnancy Testing
4.3.2.1 Global Home-use Fertility & Pregnancy Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3.3 Cholesterol Monitoring
4.3.3.1 Global Home-use Cholesterol Monitoring Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3.4 Infectious Disease
4.3.4.1 Global Home-use Infectious Disease Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.3.5 Substance Abuse Testing
4.3.5.1 Global Home-use Substance Abuse Testing Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
4.4 Veterinary
4.4.1 Global Veterinary Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 - 2019 (USD Million)
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Comparative Analysis: Global Rapid Medical Diagnostic Kits Market, by Technology (Value %)
5.1.2 Lateral flow
5.1.2.1 Global Lateral Flow Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
5.1.3 Agglutination Assays
5.1.3.1 Global Agglutination Assays Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
5.1.4 Flow-through
5.1.4.1 Global Flow-through Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
5.1.5 Solid-phase (“dipstick” assays)
5.1.5.1 Global Solid-phase Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 - 2019, (USD Million)
6.1 Overview – Current Market Scenario and Future Market Trends
6.1.1 Comparative Analysis: Global Rapid Diagnostic Kits Market, by Geography, 2012 (Value %)
6.1.2 North America
6.1.2.1 North America Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
6.1.3 Europe
6.1.3.1 Europe Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
6.1.4 Asia-Pacific
6.1.4.1 Asia-Pacific Medical Rapid Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
6.1.5 Rest of the World (RoW)
6.1.5.1 Rest of the World Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Market Strategy for Success
7.1.1 Product Innovation and Technological Advancement
7.1.2 Investing in Emerging Economies

Chapter 8 Competitive Landscape
8.1 Global Rapid Medical Diagnostic Kits Market, by Key Players: Heat Map Analysis, 2012

Chapter 9 Company Profiles
9.1 Abaxis, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Abbott Laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Alere, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Becton, Dickinson & Company
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Danaher Corporation (Beckman Coulter)
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 MegaCor Diagnostik GmbH
9.7.1 Company Overview
9.7.2 Product Portfolio
9.7.3 Business Strategies
9.7.4 Recent Developments
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Trinity Biotech plc
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Zoetis, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments

List of Figures

FIG. 1 Rapid Medical Diagnostic Kits Market Segmentation
FIG. 2 Global Rapid Medical Diagnostic Kits Market, by Applications, 2012 (USD Million)
FIG. 3 Global Rapid Medical Diagnostic Kits Market, by Technology, 2012 (USD Million)
FIG. 4 Global Rapid Medical Diagnostic Kits Market, by Geography, 2012 (USD Million)
FIG. 5 Global Rapid Medical Diagnostic Kits Market Revenue, 2011 - 2019 (USD Million)
FIG. 6 Porter’s Five Force Analysis: Global Rapid Medical Diagnostic Kits Market
FIG. 7 Market Attractiveness Analysis of Global Rapid Medical Diagnostic Kits Market, by Geography
FIG. 8 Comparative Analysis: Global Rapid Medical Diagnostic Kits Market, by Applications (Value %)
FIG. 9 Global Clinical Testing Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Clinical Infectious Disease Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Clinical Cholesterol Monitoring Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Clinical Substance Abuse Testing Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Clinical Fertility and Pregnancy Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Clinical Blood Glucose Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Home-use Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Home-use Blood Glucose Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Home-use Fertility & Pregnancy Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Home-use Cholesterol Monitoring Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Home-use Infectious Disease Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Home-use Substance Abuse Testing Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Global Veterinary Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Comparative Analysis: Global Rapid Medical Diagnostic Kits Market, by Technology (Value %)
FIG. 23 Global Lateral Flow Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Global Agglutination Assays Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Global Flow-through Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 26 Global Solid-phase Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 27 Comparative Analysis: Global Rapid Medical Diagnostic Kits Market, by Geography, 2012 (Value %)
FIG. 28 North America Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 29 Europe Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 30 Asia-Pacific Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 31 Rest of the World Rapid Medical Diagnostic Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 32 Heat Map Analysis for Key Market Players of Global Rapid Medical Diagnostic Kits Market
FIG. 33 Abaxis Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 35 Alere, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 36 Becton Dickinson: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 37 Bio-Rad Laboratories: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 38 Danaher Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 39 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 40 Trinity Biotech: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 41 Zoetis Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot, Rapid Medical Diagnostic Kits Market
TABLE 3 Global Rapid Medical Diagnostic Kits Market, by Application, 2011 – 2019 (USD Million)
TABLE 4 Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 – 2019 (USD Million)
TABLE 5 Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 – 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • F. Hoffmann-La Roche Ltd.
  • MegaCor Diagnostik GmbH
  • Trinity Biotech plc
  • MORE

Rapid medical diagnostics are tools for detection of various infectious diseases caused by virus and bacteria. Since the last decade remarkable prevalence of infectious diseases has been observed worldwide and its morbidity rate is rapidly growing. Increased detection of new pathogens-causing infections and increasing rate of weak immune system resulting from aging of population worldwide are some of the major factors leading to increase in the infectious diseases due to which the rapid medical diagnostic kits market is showing massive growth globally. Some other factors contributing to the growth of the rapid medical diagnostic kits market include cheaper cost of the rapid medical diagnostic kits, and increasing awareness about the available technologies for diagnosis of the infectious diseases caused by virus and bacteria.

Rapid medical diagnostic kits market is mainly categorized on the basis of applications namely, clinical testing, home-use, infectious disease and veterinary and on the basis of technology used to develop rapid medical diagnostic platform namely, lateral flow technology, agglutination assays, flow-through and solid phase assays. The home–use rapid medical diagnostic application segment held the major market share of rapid medical diagnostic kits market in 2012 on account of the highly dominated blood glucose testing market. While on the technology side, lateral flow technology led the technology segment in the global rapid medical diagnostic kits market owing to presence of large number of approved rapid medical diagnostic kits with this technology. Moreover, its ease of use and quick turnaround time has been beneficial in malaria and pregnancy testing at home.

The global rapid medical diagnostic kits market is highly fragmented in nature with many companies competing in the market. Well established market players dominate this market with their proprietary products and predatory growth strategies. Patent repository of the established market players is restraining growth and entry of the new market players entering into the market. Companies such as Millipore Corporation and Alere, Inc. are seeking patent approvals to secure their market share in the rapid medical diagnostic kits market.

Geographically, North America dominates the global rapid medical diagnostic kits market and is followed by Europe. North America is expected to maintain its leading position till 2019. Asia Pacific is expected to show highest growth rate in the rapid medical diagnostic testing kits market owing to factors such as, increasing infectious disease prevalence, increasing awareness about the rapid medical diagnostic tools and increasing disposable income of the population in this region. Highest infectious disease rates in developing countries such as African countries will drive the growth of rapid medical diagnostic kits market in these countries.

Note: Product cover images may vary from those shown

- Abaxis, Inc.
- Abbott Laboratories, Inc.
- Alere, Inc.
- Becton, Dickinson & Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (Beckman Coulter)
- MegaCor Diagnostik GmbH
- F. Hoffmann-La Roche Ltd.
- Trinity Biotech plc
- Zoetis, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos